This will be a small study aimed at determining the effects of oral Immulina consumption on the immune system in elderly individuals.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Enrollment
21
University of Mississippi Medical Center
Jackson, Mississippi, United States
Interferon gamma (IFNg)
Increase in IFNg from baseline to 8 weeks
Time frame: 8 weeks
Psychological Measures
Effects of Immulina on immune biomarkers based upon psychological differences including perceived stress, anxiety, depression and worry
Time frame: 8 weeks
Optimal supplement regime
Optimizing Immulina dose for maximal immune biomarker levels observing changes in Treg, Tr1, Th3, T Helper1, T Helper 2 cells, salivary cortisol, salivary alpha amylase, Interleukin 4 and Interleukin 10 cytokine production from baseline to 8 weeks
Time frame: 8 weeks
Demographic differences
Effects of Immulina based upon demographic differences including gender, race, age, BMI and socioeconomic status
Time frame: 8 weeks
Immune biomarkers
Changes in Treg, Tr1, Th3, T Helper 1, T Helper 2 cells, salivary cortisol, salivary alpha amylase, Interleukin 4 and Interleukin 10 cytokine production from baseline to 8 weeks
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.